Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment

por Wintering, Astrid, Dvorak, Christopher C., Stieglitz, Elliot, Loh, Mignon L.
Publicado 2021

CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

por Wintering, Astrid, Ishiyama, Kenichi, Tamaki, Stanley, Tamaki, Courtney, Fandel, Joshua, Ji, Lingyun, Wood, Brent L., Shah, Nirali N., Yuan, Constance M., O’Brien, Maureen M., Loh, Mignon L., Diaz-Flores, Ernesto
Publicado 2022

Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

por Junk, Stefanie V., Schaeffeler, Elke, Zimmermann, Martin, Möricke, Anja, Beier, Rita, Schütte, Peter, Fedders, Birthe, Alten, Julia, Hinze, Laura, Klein, Norman, Kulozik, Andreas, Muckenthaler, Martina U., Koehler, Rolf, Borkhardt, Arndt, Vijayakrishnan, Jayaram, Ellinghaus, David, Forster, Michael, Franke, Andre, Wintering, Astrid, Kratz, Christian P., Schrappe, Martin, Schwab, Matthias, Houlston, Richard S., Cario, Gunnar, Stanulla, Martin
Publicado 2023